跳至主要内容
临床试验/NL-OMON53811
NL-OMON53811招募中不适用

TRUE-GRIT: Reducing cognitive impairment in glioma with repetitive transcranial magnetic stimulation and cognitive strategy training - TRUE-GRIT

Vrije Universiteit Medisch Centrum0 个研究点目标入组 16 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - >= 18 years of age
  • - Histological diagnosis of diffuse glioma (WHO grade 2,3, or 4)
  • - Subjective cognitive impairment, defined as CFQ-score >= 44
  • - Stable disease, i.e. no oncological treatment for <= 2 months prior to
  • inclusion; no radiological progression on the most recent MRI, not older than 6
  • months, and no clinical progression at inclusion
  • - Stable dosage (for at least 8 weeks) of anti-epileptic medication

排除标准

  • - Current pregnancy or have given birth less than three months ago
  • - Current other treatment for cognitive complaints
  • - Karnofsky performance score <70
  • - A diffuse glioma located in the parietal cortex
  • - TMS exclusion: implanted medical devices (e.g. pacemaker, deep brain
  • stimulator, cochlear implants, medical infusion device, etc.); metal in the
  • body; dose change in antiepileptic drugs in the last 8 weeks; use of
  • pro-convulsive drugs; substance misuse or withdrawal; sleep deprivation
  • - MRI exclusion: extreme claustrophobia or metallic objects in or on the body

研究者

相似试验